Blue Jet Healthcare declares Re 1.20 dividend per share for FY26
- Blue Jet Healthcare declared a dividend of Re 1.20 per share for FY26
- Shareholders adopted audited financial statements for the year ended March 31, 2026
- Directors Naresh Shah, Akshay Arora, and Shiven Arora were re-appointed
- M/s. KKC & Associates LLP retained as statutory auditors

*this image is generated using AI for illustrative purposes only.
Blue Jet Healthcare declared a dividend of Re 1.20 per equity share for FY26 during its 58th annual general meeting. The event took place on September 21, 2026, via video conferencing.
The meeting commenced at 11:00 am with Chairman Akshay Bansarilal Arora presiding. Shareholders approved the adoption of audited standalone financial statements for the year ended March 31, 2026. The auditors' report contained no qualifications or adverse remarks.
Key Resolutions
Members passed ordinary resolutions to re-appoint Mr. Naresh Suryakant Shah as a director retiring by rotation. The company also re-appointed M/s. KKC & Associates LLP as statutory auditors.
Special resolutions secured approval for the re-appointment of Akshay Bansarilal Arora as whole-time director and executive chairman, alongside Shiven A. Arora as managing director.
Voting Process
Remote e-voting was facilitated by MUFG Intime India Private Limited from September 18 to September 20, 2026. Ms. Nupur Gadekar served as the scrutinizer for the e-voting process. The AGM concluded at 11:44 am.
Historical Stock Returns for Blue Jet Healthcare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +1.02% | +2.21% | -4.31% | +51.60% | -14.96% | +40.57% |
How does the Re 1.20 dividend per share compare to Blue Jet Healthcare's historical payout ratios and peer averages in the healthcare sector?
What strategic initiatives or capital allocation plans has management outlined to sustain growth following the re-appointment of key leadership figures?
Given the clean audit report, are there any specific operational metrics or revenue streams highlighted in the FY26 standalone financials that drove performance?


































